Sign In
Buy HIMS
$28.01
+0.500 (+1.82%)
At Close: Jun 04, 2026
Hims & Hers: Selling Options On This High-Growth Gem Could Yield 20% Or More (Rating Upgrade)
05:17pm, Monday, 28'th Apr 2025
Hims & Hers boasts excellent underlying performance, but the stock's current valuation remains uncomfortably high. Despite a 40% drop in stock price, shares are not yet a value, and selling put option
Hims & Hers Health, Inc. (HIMS) Earnings Expected to Grow: Should You Buy?
11:05am, Monday, 28'th Apr 2025
Hims & Hers Health (HIMS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Hims & Hers Health, Inc. (HIMS) Stock Drops Despite Market Gains: Important Facts to Note
06:50pm, Friday, 25'th Apr 2025
In the closing of the recent trading day, Hims & Hers Health, Inc. (HIMS) stood at $28.10, denoting a -0.14% change from the preceding trading day.
Hims & Hers: Look Past Near-Term GLP-1 Risks, This Is A Great Dip To Buy
11:21am, Wednesday, 23'rd Apr 2025
Hims & Hers stock has dropped over 60% from its peak due to concerns about its GLP-1 business, presenting a buying opportunity for long-term investors. The company is ramping up liraglutide manufactur
Hims, Keeps and other companies advertise topical finasteride with limited disclosures of side effects.
Is Most-Watched Stock Hims & Hers Health, Inc. (HIMS) Worth Betting on Now?
10:06am, Tuesday, 22'nd Apr 2025
Recently, Zacks.com users have been paying close attention to Hims & Hers Health (HIMS). This makes it worthwhile to examine what the stock has in store.
Hims & Hers: Top Pick For The Next Decade
12:35pm, Monday, 21'st Apr 2025
Hims & Hers has shown explosive growth, with potential revenue of $2.5B in FY25, trading at a low 2.4x FY25 sales. Despite the high short interest and bear arguments, HIMS' data-driven personalizati
3 Medical Info Systems Stocks to Ride the AI Wave in Trump Tariff Era
06:40am, Monday, 21'st Apr 2025
Zacks Medical Info Systems industry stocks like VEEV, HIMS and BFLY are expected to gain from the Stargate Project and provide relief amid tariff tension.
Investment strategist picks 3 ‘new age' healthcare stocks to buy
06:42am, Sunday, 20'th Apr 2025
Investment strategist Shay Boloor has highlighted three companies driving the “new age” of healthcare, making them must-watch opportunities for investors.
Bull of the Day: Hims & Hers Health (HIMS)
06:20am, Friday, 18'th Apr 2025
Zacks Names #1 Semiconductor Stock It's only 1/9,000th the size of NVIDIA which skyrocketed more than +800% since we recommended it. NVIDIA is still strong, but our new top chip stock has much more ro
Hims & Hers Health, Inc. (HIMS) Surpasses Market Returns: Some Facts Worth Knowing
06:50pm, Thursday, 17'th Apr 2025
In the closing of the recent trading day, Hims & Hers Health, Inc. (HIMS) stood at $27.23, denoting a +1.04% change from the preceding trading day.
3 Undervalued Medical Device Stocks to Buy in 2025 Amid Tariff Woes
10:55am, Thursday, 17'th Apr 2025
Here, we discuss three medical device stocks ,COR, HIMS and PBH, that offer cheap valuations, making them attractive bets amid tariff risks.
Hims & Hers Stock Gains 5.8% in 3 Months: Here's How to Play it
09:45am, Wednesday, 16'th Apr 2025
HIMS is enhancing offerings and expanding its health and wellness products and services to solidify its footing. However, macro challenges are likely to hurt its performance.
Hims & Hers Health, Inc. (HIMS) Rises But Trails Market: What Investors Should Know
06:50pm, Friday, 11'th Apr 2025
In the closing of the recent trading day, Hims & Hers Health, Inc. (HIMS) stood at $27.23, denoting a +1.57% change from the preceding trading day.
Hims' Weight Loss Expansion: Real Growth or Just Hype?
08:00am, Thursday, 10'th Apr 2025
One of the more hotly debated stocks in the market, Hims & Hers Health NYSE: HIMS, recently made an interesting announcement. The healthcare company said that it will now offer branded Zepbound, Eli L
